乙肝康治疗慢性乙型肝炎近期疗效分析
The clinical therapeutic outcomes of Yigankang in treatment of chronic hepatitis B patients
-
摘要: 目的 评价中药复合制剂乙肝康对慢性乙型肝炎治疗作用。方法 选择HBeAg、HBV-DNA阳性,肝功能异常的31例慢性乙型肝炎作治疗对象,给予乙肝康10mL加入5%葡萄糖250mL内每日滴注1次,疗程3个月,并与25例静滴甘利欣,泰特病人作对照。结果 完全应答11例,部分应答13例,无应答7例。HBV-DNA14例阴转(45.1%),HBeAg11例阴转(35.5%),其中 9例HBeAg/抗HBe血清转换(29%)。结论 乙肝康具有治疗慢性乙型肝炎肝功能的作用,同时具有清除体内病毒的作用,值得进一步研究。Abstract: Objective To evaluate the clinical therapeutic outcomes of Yigankang in treatment chronic hepatitis B patients.Methods 31 patients with HBeAg(+),HBV-DNA(+)were treated by routine therapy with Yigankang for 3 months,and 25 patients as control were investigated meantime.Results The serum HBeAg negative conversion rate was 35.5% and the serum HBV-DNA negative was 45.1% after treatment.The serum HBeAg and HBeAb conversion rate was 29%.Conclusion Yigankang can improve the liver function of chronic hepatitis B,and it can eliminate HBV.
-
Key words:
- Yigankang /
- chronic hapatitis B /
- efficacy
-
点击查看大图
计量
- 文章访问数: 1957
- HTML全文浏览量: 235
- PDF下载量: 949
- 被引次数: 0
下载:
